Penetrance

Our bodies have tiny plans.

These plans tell us how to grow. Some plans might make us sick. But not everyone gets sick.

Some plans always cause a sickness. Everyone with that plan will feel it. Other plans only affect some people. This can happen because of age. It can also happen because of how we live.

Sometimes, a plan works differently in boys or girls. This can change who gets sick. Other small changes in our body can also help. These changes can stop a sickness from starting.

It is a big mystery. Do you wonder how it works?

Our bodies use genes to work. Some genes have a change called a mutation. This change might lead to a trait or a sickness.

Penetrance is a way to measure this. It tells us how many people with a mutation actually show signs of it. If 100% of people show the trait, it has complete penetrance. This means everyone with that gene will feel the effects.

Some mutations have reduced penetrance. This means not everyone gets sick. For example, a BRCA1 gene change can cause breast cancer. By age 70, about 65% of women with this change will get cancer. The others are non-penetrant. They have the change but stay healthy.

Many things can change how a gene works. Age can matter. Some sicknesses only show up as people get older. Gender can also matter. The BRCA2 change is much more common in women than men.

Other things like diet or stress can help. Even tiny parts of the cell can change how a gene acts. These are called epigenetic changes. They can change how a gene works without changing the gene itself.

Have you ever wondered why some people look just like their parents? Our bodies use genes to guide how we grow and function. Sometimes, a gene has a small change called a mutation. This mutation can lead to a specific trait or even a disease.

Scientists use a special word called penetrance to describe this. Penetrance is the percentage of people with a mutation who actually show signs of it. It helps us understand the link between our genes and what we see in our bodies.

How does penetrance work in real life? If every single person with a mutation shows the trait, it has complete penetrance. A condition called Neurofibromatosis type 1 shows this pattern. However, many mutations have reduced penetrance. This means some people carry the mutation but stay healthy.

These healthy people are called non-penetrant. They can still pass the mutation to their children. This can lead to surprises in families where parents seem fine but their children get sick.

Scientists have studied many different ways penetrance can change. One way is called age-dependent penetrance. This means signs of a disease might not appear until a person gets older. For example, a change in the C9orf72 gene can cause certain brain issues. It is often non-penetrant until age 35. By age 60, it is 50% penetrant. By age 80, it is almost completely penetrant.

Other factors like gender and environment also play a big role. Some mutations show gender-related penetrance. The BRCA2 mutation is much more common in women than in men. By age 70, about 86% of women with this mutation get breast cancer. In contrast, only about 6% of men with it do.

Other factors include diet, stress, and even how our cells are marked. These marks are called epigenetic changes. They can change how a gene works without changing the DNA itself.

It can be quite hard for scientists to measure penetrance perfectly. They must watch out for something called ascertainment bias. This happens if they only study families who are already sick. This can make a disease seem more common than it really is. They also look for phenocopies. A phenocopy is when an environmental factor makes a person look like they have a genetic disease. New tools like Cardiac Magnetic Resonance help doctors tell these apart. This helps them give the right care to every person.

In the study of genetics, scientists look at the relationship between our DNA and our physical traits. A genotype refers to the specific version of a gene, or allele, that an individual carries. A phenotype is the actual physical trait or clinical symptom that is expressed. Penetrance is the proportion of individuals with a specific genotype who actually express the associated phenotype.

Understanding penetrance is vital in medical genetics. It helps doctors predict how likely a person is to develop a disease if they carry a mutation. It explains why two people with the same genetic change might have very different health outcomes.

To understand how this works, we must distinguish penetrance from variable expressivity. Penetrance only asks if the trait shows up at all. It is an all-or-nothing measurement for each individual. Variable expressivity, however, describes the degree or severity of the symptoms shown.

For example, two people might both have a disease-causing mutation. One person might show very mild symptoms, while the other shows severe symptoms. This difference in severity is expressivity, not penetrance. Penetrance simply tracks whether the person is a carrier who shows symptoms or a carrier who does not.

Scientists categorize penetrance into different levels based on how often a trait appears. Complete penetrance occurs when 100% of individuals with a specific genotype express the trait. An example is Neurofibromatosis type 1 (NF1), an autosomal dominant condition. Every person who inherits the disease-causing variant of this gene will develop symptoms. Reduced penetrance occurs when less than 100% of people with the genotype show the trait. In these cases, some individuals are considered non-penetrant. These non-penetrant individuals carry the mutation but show no clinical signs or symptoms. This can lead to healthy parents passing a mutation to their children.

Many factors can influence whether a mutation becomes penetrant. One major factor is age-dependent penetrance. This happens when clinical signs appear more frequently as a person gets older. Some diseases are non-penetrant until a certain age, then the penetrance increases drastically. A specific hexanucleotide repeat expansion in the C9orf72 gene is a clear example. This mutation causes amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is non-penetrant until age 35. By age 60, it is 50% penetrant, and it is almost completely penetrant by age 80.

Gender can also play a significant role through gender-related or sex-dependent penetrance. In some cases, a mutation is much more common in one sex. This might happen because of sex steroid-responsive genes or organs found only in one sex. The BRCA2 mutation provides a striking example of this. By age 70, about 86% of women with this mutation develop breast cancer. In contrast, only about 6% of men with the same mutation develop it.

Some disorders are even sex-limited. Familial male-limited precocious puberty (FMPP) is caused by a mutation in the LHCGR gene. It is only penetrant in males, while the same genotype is non-penetrant in females.

Other complex biological mechanisms influence these outcomes. Genetic modifiers are other mutations that can change how a primary mutation affects a person. These modifiers do not cause the disease themselves, but they can hinder or alter the phenotype. Environmental modifiers also matter. Factors like diet, smoking, stress, and alcohol intake can influence penetrance. For instance, researchers study how breastfeeding or pregnancy affects BRCA1 and BRCA2 mutations.

Epigenetic regulation is another factor. This involves changes like DNA methylation or histone modifications. These changes affect how genes work without changing the actual DNA sequence. In one study of identical twins, one twin developed cancer while the other did not. The affected twin showed increased methylation of the BRCA1 gene, likely due to environmental factors.

Measuring penetrance accurately is a difficult task for researchers. They must avoid ascertainment bias, which occurs if sampling is not systematic. If scientists only study families who already have a condition, they may overestimate penetrance. Large-scale population studies are more accurate but can suffer from healthy-participant-bias. Researchers also watch for phenocopies. A phenocopy is when environmental factors cause an illness that mimics a genetic disease. For example, new Cardiac Magnetic Resonance (CMR) technology shows that some cases of Hypertrophic Cardiomyopathy (HCM) are actually phenocopies. Distinguishing these allows for much more efficient medical treatment.